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The Three R’s  
 Reporting to the FDA 
 Record Retention 
 Responsibilities-both as a sponsor and as 
an investigator 
The Sponsor and The 
Investigator 
 Sponsor means a person who takes 
responsibility for and initiates a clinical 
investigation. 
 Investigator means an individual who 
actually conducts the research (drug 
administered under their immediate 
direction) 
 If there is a team, the Investigator is the 
responsible leader 
 Sub-investigator includes any other member 
of the team 
Sponsor-Investigator 
 An individual who both initiates and 
conducts an investigation, and under 
whose immediate direction the 
investigational drug is administered or 
dispensed. 
 The requirements described in 21 CFR 
Part 312 for sponsor and investigator both 
apply to this individual. 
Reporting 
 New protocols 
 Changes in the protocol 
 New investigator 
 Information amendments 
 IND safety/adverse event reports 
 Annual reports 
 Withdrawing the IND 
 Discontinuation of investigation 
 Financial diclosure 
Record Keeping/Retention 
 Drug accountability 
 Financial interests 
 Case Histories 
Responsibilities:   
The Sponsor 
 General responsibilities: 
 selecting qualified investigators and providing them 
with the information they need to conduct an 
investigation properly.  
 ensuring proper monitoring of the investigation.   
 ensuring that the investigation is conducted in 
accordance with the general investigational plan and 
protocols contained in the IND. 
 maintaining an effective IND with respect to the 
investigations. 
 ensuring that FDA and all participating investigators 
are promptly informed of significant new adverse 
effects or risks with respect to the drug. 
Responsibilities:   
The Sponsor 
 Responsible for the selection and monitoring of 
investigators  
 selecting qualified investigators and monitors.   
 ensuring that the study drug is shipped only to 
participating investigators. 
 informing co-investigators of new observations with 
regard to the investigational drug and progress of the 
study. 
 reviewing on-going investigations, including assuring 
compliance of all investigators with the protocol, 
reviewing and evaluating safety and efficacy data of 
the investigational drug, and discontinuing studies 
that are deemed to pose an unreasonable and 
significant risk to subjects. 
 
Responsibilities:   
The Sponsor 
 Other responsibilities: 
 Record keeping and record retention 
 Inspection of sponsor records and reports 
 Disposition of unused supply of 
investigational drug  
Responsibilities:   
The Investigator 
 General responsibilities of investigators: 
 ensuring that an investigation is conducted 
according to the signed investigator statement, 
the investigational plan, and applicable 
regulations.  
 protecting the rights, safety, and welfare of 
subjects under the investigator’s care  
 ensuring the control of drugs under 
investigation.  
 
Responsibilities:   
The Investigator 
 Other responsibilities: 
 Control of the investigational drug 
 Investigator record keeping and retention 
 Investigator reports 
 Inspection of sponsor-investigator reports 
and records 
 Handling of controlled substance 
Statement of the Investigator 
 
Investigator Assurance:  
HRPO 
 
  Additional references: 
 FDA Form1572 – Statement of Investigator  
 FDA Form 3454 – Certification: Financial Interests 
and Arrangements of Clinical Investigators 
 FDA Form 3455 – Disclosure:  Financial Interests 
and Arrangements of Clinical Investigators 
 Clinical Research Forms Library 
 HRPO Investigator Assurance of Commitment to 
Responsible Research 
 
